NewsMarketsSecond Cannabis Investment For UK Tobacco Firm

Second Cannabis Investment For UK Tobacco Firm

-

BRITISH tobacco giant Imperial has demonstrated its ambition in the legal cannabis industry with a second foray into the sector.

A recent £75m investment will provide Canadian firm Auxly Cannabis Group access to Imperial’s vaping technology.

This follows its initial investment into fellow UK firm Oxford Cannabis Technologies (OCT) in June, 2018.

Imperial, which makes the Lambert & Butler and Golden Virginia tobacco brands, say the Auxly move is part of an ongoing diversification strategy, which has seen it develop a growing presence in the heated tobacco and electronic vaping sectors.

Matthew Phillips, Imperial’s Chief Development Officer said: “Diversifying our Next Generation Product portfolio with this investment provides Imperial with further options for future growth and builds on last year’s investment in Oxford Cannabinoid Technologies.” 

Toronto-listed Auxly is strongly focused on developing the ‘Generation 2’ Canadian cannabis products, namely; edibles, vapes and lotions which were approved for sale last last year.

The deal gives Bristol-based Imperial a 19.9% stake in Auxly through a three-year convertible loan at a price of 81 cents per share.

OCT is a medical cannabis research company, Backed by Snoop Dogg’s venture firm and Star Wars actor Patrick Stewart, which says it aims to ‘unravel the secrets of a plant that has been stigmatised for decades’. 

Imperial is the latest consumer goods company to make a foray into cannabis. Last year Marlboro maker Altria Group announced a $2.4 billion investment in Cronos Group. 

Tilray has struck an agreement to collaborate on medical cannabis with Sandoz AG, part of the Novartis pharmaceutical Group and Canada’s Canopy Growth is receiving over $5 billion of investment from alcohol giant Constellation Brands.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global...

Transparency For Cannabis Pilot Trials In Switzerland

PRESS RELEASE FOR the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the...

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical...

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

Must read

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide...

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre...

You might also likeRELATED
Recommended to you